Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters

被引:3
|
作者
Cohen, R. [1 ,2 ]
机构
[1] Hop Intercommunal Creteil, Microbiol Serv, F-94010 Creteil, France
[2] Assoc Clin & Therapeut Infantile Val Marne ACTIV, F-94010 Creteil, France
来源
ARCHIVES DE PEDIATRIE | 2008年 / 15卷
关键词
D O I
10.1016/S0929-693X(08)74216-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The progress in the knowledge of antibiotic action mechanism have led to determine phamacodynamic/pharmacokinetic (PK/PD) parameters predictive of antibiotic efficacy in bacterial infections. These parameters could vary according to the antibiotic compound, the bacterial specie implicated, the localization of the infection, the severity of the disease. The serum PK/PD parameters are predictive of efficacy in several infections (respiratory, skin, bone) and become a major criterion for selecting antibiotics in clinical practice. Moreover, these PK/PD parameters are the cornerstone of pre-clinical development of antibiotics, the determination of dosage and for the establishment of breakpoints for classifying strains in the sensitive or resistant area, (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S53 / S58
页数:6
相关论文
共 50 条
  • [1] Definitions and implications of the pharmacokinetic-pharmacodynamic parameters of antibiotics in pediatric clinical practice
    Cohen, Robert
    Tauzin, Manon
    Rybak, Alexis
    Ouldali, Naim
    Grimprel, Emmanuel
    INFECTIOUS DISEASES NOW, 2023, 53 (08):
  • [2] How pharmacokinetic-pharmacodynamic (PK-PD) parameters influence antibiotic use
    Mazzei, T.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 : 19 - 21
  • [3] Definitions and involvments of pharmacokinetic-pharmacodynamic parameters of antibiotics in pediatric clinical practice
    Cohen, R.
    Grimprel, E.
    ARCHIVES DE PEDIATRIE, 2016, 23 : S6 - S9
  • [4] A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime
    Sánchez-Navarro, A
    Colino, CI
    Recio, MMS
    CLINICAL PHARMACOKINETICS, 2001, 40 (02) : 125 - 134
  • [5] A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime
    Sánchez-Navarro A.
    Colino C.-I.
    Sánchez Recio M.M.
    Clinical Pharmacokinetics, 2001, 40 (2) : 125 - 134
  • [6] PRELIMINARY PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THEOPHYLLINE AND ITS POSSIBLE CLINICAL IMPLICATIONS
    HEGER, RJ
    BRADBERRY, JC
    HOOVER, D
    VADIEI, K
    ODELL, D
    YOUNG, D
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 505 - 505
  • [7] Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibiotic
    Dowell, James A.
    Goldstein, Beth R.
    Buckwalter, Mary
    Stogniew, Martin
    Damle, Bharat
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1063 - 1068
  • [8] Pharmacokinetic-pharmacodynamic modelling of antibiotic therapy in severe sepsis
    Duszynska, Wieslawa
    ANAESTHESIOLOGY INTENSIVE THERAPY, 2012, 44 (03) : 158 - 164
  • [9] Pharmacokinetic-pharmacodynamic modeling before clinical study
    Cortinez, Luis I.
    PEDIATRIC ANESTHESIA, 2023, 33 (04) : 276 - 277
  • [10] PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIP
    BAGGOT, JD
    ANNALES DE RECHERCHES VETERINAIRES, 1990, 21 : S29 - S40